BRIEF—Brazilian firm expands footprint in Ontario

Biolab Pharma is to retrofit a facility in Ontario, Canada, creating a new 13,000 square foot R&D center to develop cardiology and dermatology drugs for the European market.

Ontario is investing up to C$2.8 million ($2.2 million) in the project, part of a larger overall investment by the company valued at C$57.4 million.

The project is scheduled for completion in December 2022.

Ontario is the largest life sciences jurisdiction in Canada, with more than 50% of the country’s total life sciences economic activity. Ontario employs approximately 60,000 people in this sector.